• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by MetLife Inc.

    2/24/26 4:46:23 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    FWP 1 d945331dfwp.htm FWP FWP

    Filed pursuant to Rule 433

    February 24, 2026

    Relating to

    Preliminary Prospectus Supplement dated February 24, 2026 to

    Prospectus dated May 16, 2025

    Registration Statement No. 333-287370

     

    LOGO

    MetLife, Inc.

    $1,000,000,000 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056

    Final Term Sheet

    February 24, 2026

    The information in this final term sheet relates to the offering of the securities specified herein and should be read together with the preliminary prospectus supplement dated February 24, 2026 (the “Preliminary Prospectus Supplement”), including the documents incorporated by reference therein, and the accompanying prospectus dated May 16, 2025, filed pursuant to Rule 424(b) under the Securities Act of 1933 (Registration Statement File No. 333-287370). This final term sheet is qualified in its entirety by reference to the Preliminary Prospectus Supplement. Capitalized terms used but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus Supplement.

     

    Issuer:    MetLife, Inc. (“Issuer”)
    Securities:    5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056 (“Debentures”)
    Ranking:    Subordinated Unsecured (junior to all existing and future Senior Indebtedness; on parity with the Issuer’s 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055; senior to all existing and future equity securities and the Junior Subordinated Obligations)
    Anticipated Ratings (Outlook)*:    Baa1 (Stable) / BBB (Stable) / BBB (Stable) (Moody’s / S&P / Fitch)
    Aggregate Principal Amount:    $1,000,000,000
    Price to the Public:    100.000% of principal amount, plus accrued interest, if any, from February 26, 2026
    Underwriting Discount:    1.000%
    Net Proceeds**:    $990,000,000
    Maturity Date:    March 15, 2056
    Trade Date:    February 24, 2026
    Settlement Date***:    February 26, 2026 (T+2)
    Interest Reset Date:    March 15, 2036 (“Initial Interest Reset Date”) and each date falling on the five-year anniversary of the preceding Interest Reset Date


    Interest Reset Period:    The period from, and including, the Initial Interest Reset Date to, but excluding, the next following Interest Reset Date and thereafter each period from, and including, each Interest Reset Date to, but excluding, the next following Interest Reset Date
    Interest Payment Dates:    Subject to the Option to Defer Interest Payments, semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2026, and ending on the Maturity Date
    Interest Rate:    Subject to the Option to Defer Interest Payments, (i) 5.850%, accruing from, and including, February 26, 2026, to, but excluding, the Initial Interest Reset Date or any earlier redemption date; (ii) from, and including, the Initial Interest Reset Date, during each Interest Reset Period, at an annual rate equal to the Five-Year Treasury Rate as of the most recent Reset Interest Determination Date plus 1.817%
    Option to Defer Interest Payments:    So long as no Event of Default with respect to the Debentures has occurred and is continuing, the Issuer has the right to defer the payment of interest on the Debentures for one or more consecutive Interest Periods that do not exceed five years for any single Optional Deferral Period. The Issuer may not defer interest beyond the Maturity Date, any earlier accelerated Maturity Date arising from an Event of Default or any other earlier redemption of the Debentures. During an Optional Deferral Period, interest will continue to accrue on the Debentures at the then-applicable rate described above and deferred interest on the Debentures will bear additional interest at the then-applicable interest rate, compounded on each Interest Payment Date, subject to applicable law. If the Issuer has paid all deferred interest (including compounded interest thereon) on the Debentures, the Issuer can again defer interest payments on the Debentures as described above.
    Day Count Convention:    30/360
    Optional Redemption:   

    Redeemable in whole, at any time, or in part, from time to time, (i) on any Interest Payment Date on or after the Initial Interest Reset Date, at a redemption price equal to 100% of the principal amount of Debentures being redeemed, and (ii) prior to the Initial Interest Reset Date, at a redemption price equal to the greater of

     

    (1)   100% of the principal amount of the Debentures to be redeemed, and

     

    2


      

    (2)   (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the Debentures matured on the Initial Interest Reset Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 30 basis points less (b) interest accrued to, but excluding, the redemption date;

     

    plus, in each case, accrued and unpaid interest thereon to, but excluding, the redemption date; provided that if the Debentures are not redeemed in whole, at least $25 million aggregate principal amount of the Debentures, excluding any Debentures held by MetLife, Inc. or any of its affiliates, must remain outstanding after giving effect to such redemption and all accrued and unpaid interest, including deferred interest (including compounded interest thereon), must be paid in full on all outstanding Debentures for all Interest Periods ending on or before the redemption date.

    Redemption after the Occurrence of a Tax Event, Rating Agency Event or Regulatory Capital Event:    Redeemable in whole, but not in part, at any time, within 90 days after the occurrence of a “Tax Event,” a “Rating Agency Event” or a “Regulatory Capital Event” at a redemption price equal to (i) in the case of a Tax Event or a Regulatory Capital Event, 100% of their principal amount plus accrued and unpaid interest to, but excluding, the redemption date or (ii) in the case of a Rating Agency Event, 102% of their principal amount plus accrued and unpaid interest to, but excluding, the redemption date.
    Denominations:    $2,000 and integral multiples of $1,000 in excess thereof
    CUSIP:    59156R CR7
    ISIN:    US59156RCR75
    Joint Book-Running Managers:   

    Barclays Capital Inc.

    BofA Securities, Inc.

    Citigroup Global Markets Inc.

    Goldman Sachs & Co. LLC

    Morgan Stanley & Co. LLC

    Wells Fargo Securities, LLC

    Senior Co-Managers:    BNP Paribas Securities Corp.
    Deutsche Bank Securities Inc.
    J.P. Morgan Securities LLC
    Mizuho Securities USA LLC
    SG Americas Securities, LLC
    SMBC Nikko Securities America, Inc.
    TD Securities (USA) LLC

     

    3


    Co-Managers:    BMO Capital Markets Corp.
    HSBC Securities (USA) Inc.
    Santander US Capital Markets LLC
    Scotia Capital (USA) Inc.
    Truist Securities, Inc.
    U.S. Bancorp Investments, Inc.
    Junior Co-Managers:    AmeriVet Securities, Inc.
    Drexel Hamilton, LLC
    Independence Point Securities LLC

     

    *

    Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

    **

    Net Proceeds are net of Underwriting Discount and prior to expenses.

    ***

    It is expected that delivery of the Debentures will be made on or about February 26, 2026, which will be the second business day (T+2) following the date hereof. Under Rule 15c6-1 under the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day (T+1), unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Debentures more than one business day prior to the scheduled settlement date will be required, by virtue of the fact that the Debentures will initially settle in T+2, to specify an alternative settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the Debentures who wish to trade the Debentures more than one business day prior to the scheduled settlement date should consult their own advisors.

    The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling Barclays Capital Inc. toll-free at 1-888-603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322, Citigroup Global Markets Inc. toll-free at 1-800-831-9146, Goldman Sachs & Co. LLC toll-free at 1-866-471-2526, Morgan Stanley & Co. LLC toll-free at 1-866-718-1649 or Wells Fargo Securities, LLC toll-free at 1-800-645-3751.

     

    4

    Get the next $MET alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/6/2026$97.00Outperform → In-line
    Evercore ISI
    12/16/2025$101.00Outperform
    Mizuho
    9/19/2025$84.00Overweight → Neutral
    Piper Sandler
    9/16/2025$95.00Outperform
    Wolfe Research
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    More analyst ratings

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MetLife Appoints Two Experienced Leaders to Board of Directors

    MetLife, Inc. (NYSE:MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the "Board"), effective immediately. Both leaders bring significant leadership and business experience to their roles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224365562/en/MetLife today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors, effective immediately. Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as presiden

    2/24/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference

    MetLife, Inc. (NYSE:MET) today announced that Ramy Tadros, regional president of MetLife's U.S. Business and head of MetLife Holdings, will participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on Wednesday, March 4, 2026, beginning at 10:25 a.m. (ET). A live webcast of the presentation will be available over the internet at https://event.summitcast.com/view/VSr8zRPFYu9jT7Rm69ptdC/fnXahDQq5cAwNB3QpWHPxq. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation will be available until Wednesday, March 11, 2026, at 11:59 p.m. (ET) a

    2/18/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    "Job Hugging" Is Undermining Workplace Outcomes: New MetLife Study

    56% of employees are staying put out of necessity as financial and job pressures escalate Amid persistent job market volatility and financial pressures, new MetLife data shows that while employee loyalty is rising, it may be for the wrong reasons. The latest findings from MetLife's 2026 Employee Benefit Trends Study reveal that while 77% of employees intend to stay1 with their current employer, 56% are staying out of necessity rather than genuine commitment. This comes as financial confidence among employees has fallen to its lowest level since 2012 and 31% say a primary reason for staying is that the uncertain job market makes it too risky to leave—reinforcing need‑based retention and

    2/18/26 9:00:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MetLife downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded MetLife from Outperform to In-line and set a new price target of $97.00

    1/6/26 8:46:59 AM ET
    $MET
    Life Insurance
    Finance

    Mizuho initiated coverage on MetLife with a new price target

    Mizuho initiated coverage of MetLife with a rating of Outperform and set a new price target of $101.00

    12/16/25 8:59:16 AM ET
    $MET
    Life Insurance
    Finance

    MetLife downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded MetLife from Overweight to Neutral and set a new price target of $84.00

    9/19/25 8:25:43 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kennard William E was granted 639 shares, increasing direct ownership by 1% to 45,415 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    1/6/26 4:11:06 PM ET
    $MET
    Life Insurance
    Finance

    Director Johnson Jeh C. was granted 639 shares, increasing direct ownership by 9% to 8,064 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    1/6/26 4:11:13 PM ET
    $MET
    Life Insurance
    Finance

    Director Mumenthaler Christian Stephane was granted 639 units of Common Stock, increasing direct ownership by 43% to 2,108 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    1/6/26 4:10:52 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    SEC Filings

    View All

    SEC Form FWP filed by MetLife Inc.

    FWP - METLIFE INC (0001099219) (Subject)

    2/24/26 4:46:23 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 8-K filed by MetLife Inc.

    8-K - METLIFE INC (0001099219) (Filer)

    2/24/26 4:21:13 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 10-K filed by MetLife Inc.

    10-K - METLIFE INC (0001099219) (Filer)

    2/19/26 4:34:30 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Financials

    Live finance-specific insights

    View All

    MetLife Announces First Quarter 2026 Preferred Stock Dividend Actions

    Declares Series D, E and F Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of wh

    2/17/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces Full Year and 4Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its full year and fourth quarter 2025 results. Earnings   Return   Per Share on Equity (ROE     4Q 2025   4Q 2025 Net Income $1.17 ROE 12.0%   Adjusted Earnings $2.49 Adjusted ROE 17.6% Full Year Results Net income was $3.2 billion, or $4.71 per share. Adjusted earnings per share, excluding total notable items, up 10%1 to $8.89. Premiums, fees and other revenues (PFOs) increased 10% to $57.6 billion. Adjusted PFOs, excluding pension risk transfers (PRT), were up 5% to $49.8 billion. RIS record sales,

    2/4/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CFO John McCallion Provides Fourth Quarter and Full Year 2025 Financial Update Video

    MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a fourth quarter and full year 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204908797/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help in

    2/4/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    MetLife Appoints Two Experienced Leaders to Board of Directors

    MetLife, Inc. (NYSE:MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the "Board"), effective immediately. Both leaders bring significant leadership and business experience to their roles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224365562/en/MetLife today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors, effective immediately. Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as presiden

    2/24/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Investment Management Completes Acquisition of PineBridge Investments

    The combination brings together global scale and deep specialization, accelerating MetLife's growth in asset management MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), closed today on its acquisition of PineBridge Investments (PineBridge). The combined business manages $734.7 billion1 of assets, serving clients around the world. Accelerating growth in asset management is a top priority for MetLife in its New Frontier strategy. The acquisition brings together MIM's institutional strength and scale with PineBridge's global footprint and deep specialization to position MIM as a top-tier diversified global asset manager. "Toget

    12/30/25 5:15:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife and Global Citizen Announce Major Partnership to Drive Economic Change and Foster Resilient Communities

    MetLife Foundation Commits $9 Million to FIFA Global Citizen Education Fund Today at the 2025 Global Citizen Festival, MetLife, a leading financial services company providing insurance and employee benefits, proudly announced becoming a major partner with Global Citizen, the world's largest movement to end extreme poverty, with a new three-year partnership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250926660696/en/NEW YORK, NEW YORK - SEPTEMBER 27: (L-R) Michael Roberts and Nuria Garcia speak onstage during the 2025 Global Citizen Festival at Central Park on September 27, 2025 in New York City. (Photo by Noam Galai/Getty

    9/27/25 9:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    5/2/24 5:34:57 PM ET
    $MET
    Life Insurance
    Finance